Michael Salmon

Michael Salmon is a seasoned professional in the field of immunology and inflammation, currently serving as Senior Director at Schrödinger since November 2020. Prior experience includes roles as Independent Consultant at Michael Salmon LLC, Vice President of Platform Translation & Development at Emulate, Inc., Director at Merck, and Principal Scientist at Gilead Sciences. Michael's career began at GlaxoSmithKline as an Investigator, following a graduate position at Imperial College London. Academic qualifications include a Ph.D. in Pharmacology from Imperial College London, an MS in Neuroendocrine Cell Biology from UCL, a BS in General Biology from the University of Greenwich, and a certificate in Clinical Trials from the University of Washington.